Dive into the world of compounded drugs, uniquely crafted by pharmacies for patients when standard options fail. Discover the rising concerns over unapproved medications, particularly compounded GLP-1s, and the regulatory loopholes that enable questionable manufacturing practices. The hosts humorously critique the misleading marketing tactics promoting quick-fix solutions while advocating for FDA-approved treatments that ensure safety and effectiveness. Navigate through the complexities of compounded medications and the importance of informed medical decisions.
36:08
forum Ask episode
web_stories AI Snips
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
question_answer ANECDOTE
Mounjaro DIY Ad
Andrea Taylor saw an Instagram ad promoting a "secret recipe" for Mounjaro.
The ad claimed to make Mounjaro at home with simple ingredients, appealing to celebrity trends.
insights INSIGHT
Legality of Compounding
Compounding pharmacies legally operate by modifying existing drugs or addressing shortages.
They create alternatives, often with dose or ingredient adjustments, not available commercially.
volunteer_activism ADVICE
Alternatives to Compounded GLP-1s
Explore all options with your doctor, including insurance, coupons, and samples, before considering compounded GLP-1s.
A generic GLP-1, Victoza, is now available and may be more affordable than compounded versions.
Get the Snipd Podcast app to discover more snips from this episode
In this episode of Fat Science, Dr. Emily Cooper, Andrea Taylor and Mark Wright explore the world of compounded drugs. These are medications prepared by pharmacists to meet specific needs of patients when commercially-available products are not an option. Changes in dose, accommodating patients with allergies or sensitivities and drug shortages are some of the reasons the FDA allows compounded drugs to be made and sold.
Key Takeaways:
Compounded drugs are manufactured by pharmacies to offer alternatives to brand medications but lack FDA approval for safety and efficacy.
Loopholes in drug shortage laws have allowed a surge in compounded GLP1s, though these shortages are now being resolved.
Concerns arise over the quality, dosing, and potential immune reactions that compounded drugs might provoke, especially when not FDA-tested.
Choosing FDA-approved drugs ensures strict regulation, accountability and proper testing to safeguard health.
Consumers face aggressive marketing tactics aiming to sell compounded drugs at lower prices without guarantees of safety or effectiveness.
Fat Science is a podcast on a mission to explain where our fat really comes from and why it won’t go and stay away. We are committed to creating a world where people are empowered with accurate information about metabolism and recognize that fat isn’t a failure. This podcast is for informational purposes only and is not intended to replace professional medical advice.
If you have a question for Dr. Cooper, a show idea, feedback, or just want to connect, email us at info@diabesityinstitute.org.
Fat Science is supported by the non-profit Diabesity Institute which is on a mission to increase access to effective, science-based medical care for those suffering from or at risk for diabesity. https://diabesityresearchfoundation.org/
Fat Science